AREB vs BABA

AREB exhibits severe financial distress, as reflected in its Piotroski F-Score of 1/9 (indicating extreme weakness) and the absence of an Altman Z-Score, which raises significant bankruptcy risk. The company reports negative profitability across all margins, a negative ROA of -48.65%, and a dangerously high debt/equity ratio of 6.66. Despite a low price of $0.14, the stock is fundamentally unsound, with a 52-week low of $0.12 and a 5-year return of -100%. The lack of analyst coverage and consistent earnings misses further underscore its poor operational and market standing.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.